top of page
Abstract Guidelines

Abstract Submission & Guidelines

Abstract submission for 

the 7th Annual Heart in Diabetes is now open. 

To be published and present your poster at the conference, the author(s) must register for the 7th HiD. **

Accepted Abstracts will receive 40% OFF towards any registration.

Deadline for submission is on May 1, 2023.

***Please note: If an author wishes to make changes or withdraw their abstract, they must contact the HiD team no later than May 1th, 2023. HiD cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via e-mail to info@tmioa.com.


 

Late breaking abstracts will be open May 10 until May 22, 2023.

 

 

 

 

 

 

 

Accepted Abstracts will be published in the 

American Heart Journal

Editor-in-Chief: Daniel Mark, MD, MPH

Late Breaking Abstract Submission Deadline: May 1, 2023

  • Accepted Abstracts will be published in American Heart Journal, Editor-in-Chief: Daniel Mark, MD, MPH

  • Accepted Abstracts will have poster presentation at the meeting.

  • Top Abstracts will be selected for oral presentation at the meeting.

  • Top 4 Abstracts will receive awards and cash prizes.

 

***Please note: If an author wishes to make changes or withdraw their abstract, they must contact the HiD team no later than May 1th, 2023. HiD cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via e-mail to info@tmioa.com

 

Abstract Submission Topics

Abstracts should address state-of-the-art clinical research aspects of diabetes and the heart. (As an example, obesity by itself will NOT qualify, but obesity as it relates to diabetes and/or cardiovascular disease will qualify). 

Topics include: diabetes, hypoglycemia, prediabetes, and/or cardiometabolic syndrome, retinopathy, obesity, neuropathy, dyslipidemia, triglycerides, cholesterol, hypertension, congestive heart failure (CHF), atherosclerosis, cardiovascular disease, arrhythmia, kidney/renal disease, cardiorenal syndrome, thrombosis, coagulation abnormalities, therapeutics, clinical trials, cardiovascular outcome trials, epidemiology, fatty liver, inflammation, guidelines on practice, technology, peripheral vascular disease, and related conditions. Although the posters are not designed for basic science, abstracts which consider unknown MOA (mode of action) of medications or pathophysiology of related medical conditions may be accepted.   

Abstract Poster Presentations

Abstracts may be submitted for poster presentation. If selected for poster presentation, the author(s) or presenter(s) are required to register for the Congress and to be present during the poster sessions. The presenter in attendance must be one of the authors listed on the abstract. Poster Presentation Session Time and Date TBA.

   ​ 

Abstract Oral Presentations

Four of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session - Time and Date TBA  (once ready, 7th HiD agenda may be viewed at heartindiabetes.com/agenda). In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document in order to be considered for and to present their work at the abstract oral session.   ​ 

 

Top Abstract Awards

Awards will be given to the highest ranking abstracts. The award levels are: Gold, Silver, Bronze and honorable mention.  

 ​ 

In addition:

  • Scientific materials presented at the 7th Annual Heart in Diabetes (2023) must not have been published or presented prior to June 09, 2023, other than in abstract form.

  • All abstracts must be submitted electronically and should be no more than 250 words (Titles, author(s) names, and affiliations are not included in the word count).

  • Graphs or figures submitted must be in TIFF or JPG format.

  • All materials must arrive on or before the abstract deadline noted above.

  • Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.

  • Authorship on multiple abstracts is permitted.

  • All submitted content will be graded by the 2023 Heart in Diabetes Scientific Abstract Committee.

  • Abstracts will be published in an issue of the American Heart Journal. Click on the images to see a sample of the recently published works.  


 

american-heart-journal-640x400.jpg
Daniel Mark Editor in Chief.jpg
Table-of-Contents_2022_American-Heart-Journal-1.png
6HID Oral Abstract Winners.png

View Sample Abstract Submission



 

To play, press and hold the enter key. To stop, release the enter key.

bottom of page